Want to join the conversation?
$PFE agreed to buy $MDVN. $MDVN's portfolio includes XTANDI (enzalutamide), androgen receptor inhibitor that blocks multiple steps in androgen receptor signaling pathway within tumor cell. Also, $MDVN has promising, wholly-owned, late-stage oncology pipeline, which includes 2 development-stage oncology assets, talazoparib and pidilizumab.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!